Results from the EPCAT II trial show that aspirin was not significantly different from rivaroxaban for the prevention of deep vein thrombosis or pulmonary embolism after total hip or knee arthroplasty.
Researcher sought to determine the effectiveness of hydroxychloroquine vs placebo as an analgesic treatment of hand osteoarthritis.
The effects of combination COX-2 inhibitor therapy with metformin on joint replacement rates were examined in patients with osteoarthritis and diabetes.
In older patients with knee OA, pain expectancy may affect the pain experience after genuine and sham electroacupuncture.
Patients with end-stage knee or hip osteoarthritis may often experience neuropathic pain, particularly at rest.
Use of the 2006 Orlando criteria vs the 2007 Budapest criteria for diagnosis of CRPS may lead to misdiagnosis of unexplained pain after TKA.
There is a need for programs that are designed to decrease disparities in joint replacement use among various populations.
Many individuals who use nonsteroidal anti-inflammatory drugs tend to exceed the daily dose limit.
The use of celecoxib in patients with OA and RA was associated with a similar or a lower risk for cardiovascular, gastrointestinal, and renal adverse events compared with ibuprofen and naproxen.
Routine rehabilitation therapy along with adjunctive acupuncture may not provide a significant benefit over exercise, after total knee replacement.